Navigation Links
Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections

al information contained herein, this release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including the difficulty of predicting FDA approvals, the acceptance and demand for new pharmaceutical products, the impact of competitive products and pricing, the timely development and launch of new products, and the risk factors listed from time to time in Forest Laboratories' Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and any subsequent SEC filings.


1. DiNubile MJ, Lipsky BA. Complicated infections of skin and skin

structures: when the infection is more than skin deep. Journal of

Antimicrobial Chemotherapy (2004) 53, Suppl. S2, ii37-ii50.

2. R. Finch (2006) Gram-positive infections: lessons learnt and novel

solutions Clinical Microbiology and Infection 12 (s8) , 3-8


3. Su Young Lee, Joseph L. Kuti, David P. Nicolau. Surgical Infections.

September 1, 2005, 6(3): 283-295. doi:10.1089/sur.2005.6.283.

4. Klevens RM, Korrison MA, et al. Invasive Methicillin-Resistant

Staphylococcus aureus Infections in the United States. JAMA, October

17, 2007-Vol 298, No. 15.

5. U.S. Food and Drug Administration. Battle of the Bugs: Fighting

Antibiotic Resistance. Accessed on May 28, 2008. Available at:

6. Scheinfeld N. Journal of Drugs in Dermatology. Jan 2007. A comparison

of available and investigational antibiotics for complicated skin

infections and treatment-resistant Staphylococcus aureus and


SOURCE Forest Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
2. Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD
3. Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2b Studies
4. Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
5. Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia
6. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
7. Romark Laboratories Completes Enrollment in U.S. Phase II Study of Nitazoxanide for Chronic Hepatitis C Genotype 1 Non-Responders
8. Northfield Laboratories Inc. Presentation at FDA/NIH Workshop on Hemoglobin-Based Oxygen Carriers
9. Romark Laboratories Initiates Phase II Study of Nitazoxanide in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1
10. Romark Laboratories Raises $18 Million in Institutional Financing
11. eRT Announces the Availability of the Suicidality Monitoring System(TM) For Clinical Trials
Post Your Comments:
(Date:3/3/2015)...  This industry report package offers the most up-to-date market data on ... the world and in the top 10 global countries. Along with a ... following countries: Australia , China ... Italy , Japan , ... , United States The reports ...
(Date:3/3/2015)... PARK, Calif. , March 3, 2015  BioPharmX ... the development of novel drug delivery products to address ... announced that Jim Pekarsky , chief executive officer ... th Annual Roth Capital Partners Conference on Wednesday, ... Laguna Niguel in ...
(Date:3/3/2015)... DUBLIN , Mar. 03, 2015 Research and ... addition of the "Global POC Diagnostics Market 2015-2019" ... The analysts forecast the Global POC Diagnostics market to ... period 2014-2019. POC diagnostics are IVD ... outside a clinical laboratory setting. The use of these ...
Breaking Medicine Technology:Global Safety Glass Market to 2019 - Market Size, Top 10 Countries, Trends, and Forecasts 2BioPharmX Corporation To Present At 27th Annual Roth Capital Partners Conference On March 11, 2015 2BioPharmX Corporation To Present At 27th Annual Roth Capital Partners Conference On March 11, 2015 3Global POC Diagnostics Market 2015-2019 with Abbott Labs, Alere, Bayer Healthcare, Danaher, F. Hoffmann-La Roche & Johnson & Johnson Dominating 2
... Wis., Sept. 16 Top researchers at the Gastrointestinal ... Dallas are exploring the clinical applications of BCM-95®, a ... bioavailability. Previous studies have shown that ... forms of curcumin, and had a retention time in ...
... Mich., Sept. 16 Metabolic Solutions Development Company (MSDC), ... Association for the Study of Diabetes (EASD) annual conference ... indicates that the company,s clinical candidate, MSDC-0160, promotes the ... to the creation of more brown fat.  The research ...
Cached Medicine Technology:BCM-95 Demonstrates Superior Anti-Inflammatory Effects 2Metabolic Solutions Development Company to Present Research Findings to European Association for the Study of Diabetes 2
(Date:3/3/2015)... NJ (PRWEB) March 03, 2015 Today, ... Rice, former Seattle Seahawks wide receiver, announced the donation ... in timing with Brain Injury Awareness Month. In an ... injuries and the importance of brain health, Rice and ... field and the need to make brain health a ...
(Date:3/3/2015)... Dan E. Chambers, an experienced Los Angeles ... crimes, recently spoke on the radio to give his insights ... the Independent Journal Review radio show “The Right Mics” chose ... prosecutor and now as a criminal defense attorney would provide ... trial and sentencing of this high-profile case. , During the ...
(Date:3/3/2015)... The human augmentation market is mainly driven ... wearable augmentation sector is predicted to outpace the in-built ... years. , The eye-wear sector dominates the North ... of new products launches in the region. Furthermore, strong ... as well as the rising demand for advantageous products ...
(Date:3/3/2015)... While it is clear that the prospect ... Canadian drivers are signing up to UBI policies, more ... be enticed. Due to current regulations, the application of ... Its full capability is starting to be realised ... emergency breakdown services are at the top of the ...
(Date:3/3/2015)... 2015 DePuy Pinnacle hip lawsuits ... of the artificial hip system caused recipients to ... forward in the federal multidistrict litigation underway in ... to the most recent Master Case List issued ... Pinnacle hip replacement lawsuits are now pending in ...
Breaking Medicine News(10 mins):Health News:Steve Weatherford and Sidney Rice Reveal Donation for Brain Injury Awareness Month 2Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 2Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 3Health News:Human Augmentation Market to Pose 43.5% CAGR Through 2020, States MarketsandMarkets in its New Research Study Now Available at 2Health News:TU-Automotive: Wawanesa Insurance to Discuss How UBI Can Produce Happy, Loyal Customers 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 3Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 4
... Parents to Get Children Vaccinated, Despite Scare in ABC,s ... March of,Dimes and seven former directors of the U.S. ... not to be frightened of childhood,vaccines by the suggestion ... that the mercury-based preservative thimerosal -- which is no ...
... for small doses of Plavix in children under 2 , , ... anti-clotting drug clopidogrel (Plavix) can benefit children under age 2 ... astonished at how little of the drug they needed to ... a fifth of the amount that we were expecting," Dr. ...
... in US GAAP, TORONTO, Jan. 29 /PRNewswire-FirstCall/ - ... products and services to the global life,sciences markets, today ... first time under US GAAP. These filings include the ... the Canadian,Supplement to the annual MD&A., To assist ...
... This release is also available in Spanish . ... for many years on that using the safety belt on the ... warning with the use of such device in the front seats ... more reduced. , With such a situation on the table, the ...
... Mayo Clinic ... physician, ... caregivers, and healthcare professionals can now register,for "Inflammatory Bowel Disease: Why ... Crohn,s & Colitis,Foundation will take place on Thursday, March 6, from ...
... of,Directors of BD (Becton, Dickinson and Company) (NYSE: ... per common share. The dividend will be,payable on March ... 2008. The,indicated annual dividend rate is $1.14 per share., ... technology company that manufactures and,sells medical devices, instrument systems ...
Cached Medicine News:Health News:Childhood Vaccines Save Lives, March Of Dimes Says 2Health News:Childhood Vaccines Save Lives, March Of Dimes Says 3Health News:Anti-Clotting Drug Helps Infants With Heart Ills 2Health News:Using the safety belt in the rear seats of the car reduces death risk by almost a half 2Health News:Interactive Teleconference on Inflammatory Bowel Disease for Patients, Caregivers, and Healthcare Professionals 2
Black Spandex Above the Knee Compression Girdles with Contact Closure with Zipper...
Short Girdle, High Waist, Mid-thigh...
Uniform compression and support after multiple procedures. No uncomfortable waist band....
A One Piece Support Garment - any length or size...
Medicine Products: